SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001140361-24-007785
Filing Date
2024-02-14
Accepted
2024-02-14 10:35:19
Documents
2
Group Members
CONCENTRA BIOSCIENCES, LLCTANG CAPITAL MANAGEMENT, LLCTANG CAPITAL PARTNERS, LP

Document Format Files

Seq Description Document Type Size
1 FORM SC TO-T/A ny20018184x7_sctota.htm SC TO-T/A 32599
2 EXHIBIT (D)(7) ny20018184x7_ex-d7.htm EX-99.(D)(7) 139410
  Complete submission text file 0001140361-24-007785.txt   173734
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Subject) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-92944 | Film No.: 24633817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121
Business Address 4747 EXECUTIVE DRIVE SUITE 210 SAN DIEGO CA 92121 8582003830
Concentra Merger Sub II, Inc. (Filed by) CIK: 0002004484 (see all company filings)

IRS No.: 934813439 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A